KYMR insider transaction filings
Kymera Therapeutics, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-27. Screen KYMR transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-27 | 4 | Rooney Terence — Chief Medical Officer | Grant/award (A): 38,000 @ $0 · Grant/award (A): 76,000 (derivative) @ $0 | EDGAR |
| 2026-07-07 | 4 | Mainolfi Nello — Chief Executive Officer, Director | Option exercise (M): 50,000 @ $2.08 · Sale (S): 50,000 @ $119 · Option exercise (M): 45,559 (derivative) @ $0 · Option exercise (M): 4,441 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Jacobs Bruce N. — Chief Financial Officer | Option exercise (M): 61,378 @ $5.33 · Sale (S): 1,500 @ $110.54 · Sale (S): 1,700 @ $111.57 · Sale (S): 1,100 @ $112.79 · Sale (S): 4,110 @ $114.19 · Sale (S): 51,375 @ $114.77 · +4 more | EDGAR |
| 2026-07-02 | 4 | Goodman Noah — Chief Business Officer | Sale (S): 3,389 @ $114.29 | EDGAR |
| 2026-07-02 | 4 | Mainolfi Nello — Chief Executive Officer, Director | Option exercise (M): 80,000 @ $2.08 · Sale (S): 1,883 @ $112.80 · Sale (S): 6,626 @ $113.98 · Sale (S): 24,105 @ $114.96 · Sale (S): 44,050 @ $115.69 · Sale (S): 3,336 @ $116.56 · +1 more | EDGAR |
| 2026-07-02 | 4/A | Booth Bruce — Director | Sale (S): 5,549 @ $105.78 · Sale (S): 14,798 @ $106.63 · Sale (S): 19,419 @ $107.76 · Sale (S): 10,848 @ $108.28 · Sale (S): 7,968 @ $109.75 · Sale (S): 7,723 @ $110.67 · +8 more | EDGAR |
| 2026-06-30 | 4 | Booth Bruce — Director | Sale (S): 10,658 @ $108.28 · Sale (S): 7,833 @ $109.75 · Sale (S): 7,602 @ $110.67 · Sale (S): 907 @ $111.20 · Sale (S): 1,688 @ $108.28 · Sale (S): 1,239 @ $109.75 · +2 more | EDGAR |
| 2026-06-30 | 4 | Booth Bruce — Director | Sale (S): 28,296 @ $107.57 · Sale (S): 231,007 @ $108.14 · Sale (S): 32,624 @ $109.79 · Sale (S): 11,277 @ $110.49 · Sale (S): 10,366 @ $111.51 · Sale (S): 555 @ $112.49 · +24 more | EDGAR |
| 2026-06-26 | 4 | BVF PARTNERS L P/IL — Director BIOTECHNOLOGY VALUE FUND L P — Director BVF I GP LLC — Director BIOTECHNOLOGY VALUE FUND II LP — Director BVF II GP LLC — Director Biotechnology Value Trading Fund OS LP — Director BVF Partners OS Ltd. — Director BVF GP HOLDINGS LLC — Director BVF INC/IL — Director LAMPERT MARK N — Director | Sale (S): 837,914 @ $106.50 · Sale (S): 627,597 @ $106.50 · Sale (S): 113,289 @ $106.50 · Sale (S): 51,858 @ $106.50 | EDGAR |
| 2026-06-25 | 4 | Hrustanovic Gorjan — Director | Grant/award (A): 6,068 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | Goodman Noah — Chief Business Officer | Option exercise (M): 5,000 @ $21.05 · Sale (S): 2,500 @ $109 · Sale (S): 2,500 @ $119 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | Ridloff Elena — Director | Grant/award (A): 6,068 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | Esposito Pamela — Director | Grant/award (A): 6,068 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | Albers Jeffrey W. — Director | Grant/award (A): 6,068 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | Sandor Victor — Director | Grant/award (A): 6,068 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | Booth Bruce — Director | Sale (S): 37,179 @ $119.71 · Sale (S): 112,299 @ $120.66 · Sale (S): 40,774 @ $121.38 · Sale (S): 4,977 @ $122.67 · Sale (S): 10,860 @ $123.62 · Sale (S): 11,711 @ $124.61 · +16 more | EDGAR |
| 2026-06-25 | 4 | Booth Bruce — Director | Sale (S): 1,235 @ $99.98 · Sale (S): 173 @ $99.98 · Sale (S): 103,688 @ $100.42 · Sale (S): 14,513 @ $100.42 · Sale (S): 14,490 @ $101.14 · Sale (S): 2,029 @ $101.14 · +24 more | EDGAR |
| 2026-06-25 | 4 | Booth Bruce — Director | Grant/award (A): 6,068 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | MARAGANORE JOHN — Director | Grant/award (A): 6,068 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | BAKER BROS. ADVISORS LP — Director, 10% owner 667, L.P. — Director, 10% owner Baker Bros. Advisors (GP) LLC — Director, 10% owner Baker Brothers Life Sciences LP — Director, 10% owner BAKER FELIX — Director, 10% owner BAKER JULIAN — Director, 10% owner | Grant/award (A): 6,068 (derivative) @ $0 · Grant/award (A): 6,068 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | BVF PARTNERS L P/IL — Director BIOTECHNOLOGY VALUE FUND L P — Director BVF I GP LLC — Director BIOTECHNOLOGY VALUE FUND II LP — Director BVF II GP LLC — Director Biotechnology Value Trading Fund OS LP — Director BVF Partners OS Ltd. — Director BVF GP HOLDINGS LLC — Director BVF INC/IL — Director LAMPERT MARK N — Director | Grant/award (A): 6,068 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | Goodman Noah — Chief Business Officer | Option exercise (M): 2,500 @ $21.05 · Sale (S): 2,500 @ $99 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | Booth Bruce — Director | Sale (S): 18,313 @ $103.42 · Sale (S): 9,584 @ $104.38 · Sale (S): 2,560 @ $103.42 · Sale (S): 1,341 @ $104.38 | EDGAR |
| 2026-06-22 | 4 | Booth Bruce — Director | Option exercise (M): 11,741 @ $20 · Sale (S): 11,741 @ $89.98 · Sale (S): 92,169 @ $90.38 · Sale (S): 12,902 @ $90.38 · Sale (S): 62,897 @ $90.48 · Sale (S): 32,359 @ $91.85 · +25 more | EDGAR |
| 2026-06-03 | 4 | Jacobs Bruce N. — Chief Financial Officer | Option exercise (M): 12,653 @ $2.08 · Option exercise (M): 12,653 (derivative) @ $0 | EDGAR |
| 2026-05-27 | 4 | Chadwick Jeremy G — Chief Operating Officer | Sale (S): 3,730 @ $78.36 · Sale (S): 324 @ $79.17 · Sale (S): 3,800 @ $79.39 · Sale (S): 4,500 @ $80.02 · Sale (S): 551 @ $80.71 · Sale (S): 3,679 @ $81.50 · +1 more | EDGAR |
| 2026-05-19 | 4 | Jacobs Bruce N. — Chief Financial Officer | Option exercise (M): 15,000 @ $2.08 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2026-05-19 | 4 | Esposito Pamela — Director | Option exercise (M): 1,000 @ $31.20 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2026-05-11 | 4 | Ridloff Elena — Director | Option exercise (M): 3,000 @ $31.20 · Sale (S): 3,000 @ $87 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2026-04-29 | 4 | Mainolfi Nello — Chief Executive Officer, Director | Option exercise (M): 30,000 @ $2.08 · Sale (S): 17,005 @ $80.74 · Sale (S): 12,059 @ $81.70 · Sale (S): 936 @ $82.45 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2026-04-24 | 4 | Booth Bruce — Director | Option exercise (M): 5,641 @ $14.18 · Option exercise (M): 259 @ $20 · Sale (S): 5,900 @ $89.96 · Sale (S): 88 @ $90.08 · Sale (S): 12 @ $90.08 · Option exercise (M): 5,641 (derivative) @ $0 · +1 more | EDGAR |
| 2026-04-24 | 4 | Chadwick Jeremy G — Chief Operating Officer | Option exercise (M): 100 @ $30.17 · Option exercise (M): 200 @ $43.50 · Sale (S): 300 @ $90 · Option exercise (M): 100 (derivative) @ $0 · Option exercise (M): 200 (derivative) @ $0 | EDGAR |
| 2026-04-16 | 4 | Goodman Noah — Chief Business Officer | Sale (S): 1,347 @ $90 | EDGAR |
| 2026-04-16 | 4 | Booth Bruce — Director | Option exercise (M): 4,159 @ $14.18 · Sale (S): 4,159 @ $89.97 · Option exercise (M): 2,200 @ $14.18 · Sale (S): 2,200 @ $89.95 · Sale (S): 2,750 @ $90.10 · Sale (S): 385 @ $90.10 · +2 more | EDGAR |
| 2026-04-16 | 4 | Chadwick Jeremy G — Chief Operating Officer | Option exercise (M): 4,466 @ $30.17 · Option exercise (M): 785 @ $43.50 · Sale (S): 5,251 @ $90.00 · Option exercise (M): 1,300 @ $43.50 · Sale (S): 1,300 @ $90 · Option exercise (M): 4,466 (derivative) @ $0 · +2 more | EDGAR |
| 2026-04-10 | 4 | Goodman Noah — Chief Business Officer | Option exercise (M): 2,500 @ $21.05 · Sale (S): 3,094 @ $86.62 · Sale (S): 2,670 @ $87.11 · Sale (S): 2,500 @ $89 · Sale (S): 2,000 @ $87.35 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | Ridloff Elena — Director | Option exercise (M): 7,400 @ $14.18 · Sale (S): 7,400 @ $85.37 · Option exercise (M): 4,600 @ $14.18 · Sale (S): 3,400 @ $85.19 · Sale (S): 1,200 @ $86.05 · Option exercise (M): 7,400 (derivative) @ $0 · +1 more | EDGAR |
| 2026-04-01 | 4 | Chadwick Jeremy G — Chief Operating Officer | Option exercise (M): 7,600 @ $29.64 · Sale (S): 7,600 @ $85.38 · Option exercise (M): 14,640 @ $29.64 · Sale (S): 13,540 @ $85.41 · Sale (S): 1,100 @ $86.05 · Option exercise (M): 7,600 (derivative) @ $0 · +1 more | EDGAR |
| 2026-03-25 | 4 | Chadwick Jeremy G — Chief Operating Officer | Option exercise (M): 84,400 @ $29.64 · Sale (S): 22,756 @ $76.73 · Sale (S): 52,975 @ $77.21 · Sale (S): 8,214 @ $78.40 · Sale (S): 6,105 @ $79.87 · Sale (S): 1,200 @ $80.05 · +4 more | EDGAR |
| 2026-03-20 | 4 | Esposito Pamela — Director | Option exercise (M): 2,500 @ $49.10 · Sale (S): 700 @ $77.71 · Sale (S): 600 @ $79.24 · Sale (S): 1,200 @ $79.94 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | Chadwick Jeremy G — Chief Operating Officer | Option exercise (M): 20,000 @ $43.50 · Sale (S): 1,765 @ $82.13 · Sale (S): 12,882 @ $83.10 · Sale (S): 11,111 @ $83.72 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Goodman Noah — Chief Business Officer | Grant/award (A): 9,225 @ $0 · Grant/award (A): 18,450 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Gollob Jared — Chief Medical Officer | Grant/award (A): 17,650 @ $0 · Sale (S): 1,510 @ $87.75 · Sale (S): 1,055 @ $88.50 · Sale (S): 3,048 @ $89.66 · Sale (S): 492 @ $84.00 · Sale (S): 2,519 @ $85.04 · +3 more | EDGAR |
| 2026-03-04 | 4 | Jacobs Bruce N. — Chief Financial Officer | Grant/award (A): 17,650 @ $0 · Sale (S): 2,039 @ $87.75 · Sale (S): 1,424 @ $88.50 · Sale (S): 4,113 @ $89.66 · Sale (S): 492 @ $84.00 · Sale (S): 2,519 @ $85.04 · +3 more | EDGAR |
| 2026-03-04 | 4 | Mainolfi Nello — Chief Executive Officer, Director | Grant/award (A): 215,000 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Adams Brian — Chief Legal Officer | Grant/award (A): 4,125 @ $0 · Grant/award (A): 8,250 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Booth Bruce — Director | Sale (S): 71,814 @ $90.13 · Sale (S): 10,052 @ $90.13 | EDGAR |
| 2026-03-04 | 4 | Chadwick Jeremy G — Chief Operating Officer | Grant/award (A): 12,575 @ $0 · Sale (S): 549 @ $87.75 · Sale (S): 383 @ $88.50 · Sale (S): 1,107 @ $89.66 · Sale (S): 394 @ $84.00 · Sale (S): 2,017 @ $85.04 · +3 more | EDGAR |
| 2026-02-25 | 4 | Mainolfi Nello — Chief Executive Officer, Director | Option exercise (M): 30,000 @ $2.08 · Sale (S): 19,764 @ $89.78 · Sale (S): 5,434 @ $90.39 · Sale (S): 3,293 @ $91.76 · Sale (S): 1,501 @ $92.81 · Sale (S): 8 @ $93.49 · +1 more | EDGAR |
| 2026-02-20 | 4 | Esposito Pamela — Director | Option exercise (M): 2,500 @ $49.10 · Sale (S): 1,900 @ $87.06 · Sale (S): 600 @ $88.10 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
Recent 8-K events — Kymera Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-27 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-25 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-24 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-06-08 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-04-30 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-27 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-26 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-26 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-13 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=KYMR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →